Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort

S. Koirala, S. Borisov, E. Danila, A. Mariandyshev, B. Shrestha, N. Lukhele, M. Dalcolmo, S. R. Shakya, S. Miliauskas, L. Kuksa, S. Manga, A. Aleksa, J. T. Denholm, H. B. Khadka, A. Skrahina, S. Diktanas, M. Ferrarese, J. Bruchfeld, A. Koleva, A. PiubelloG. S. Koirala, Z. F. Udwadia, D. J. Palmero, M. Munoz-Torrico, R. GC, G. Gualano, V. I. Grecu, I. Motta, A. Papavasileiou, Y. Li, W. Hoefsloot, H. Kunst, J. Mazza-Stalder, M. C. Payen, O. W. Akkerman, E. Bernal, V. Manfrin, A. Matteelli, H. Mustafa Hamdan, M. Nieto Marcos, J. Cadiñanos Loidi, J. J. Cebrian Gallardo, R. Duarte, N. Escobar Salinas, R. Gomez Rosso, R. Laniado-Laborín, E. Martínez Robles, S. Quirós Fernandez, A. Rendon, A. Šmite, Giovanni B. Migliori

Research output: Contribution to journalArticlepeer-review

43 Citations (Scopus)
5 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Neuroscience